Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Advanced Accele. Ads (AAAP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,590,087
  • Shares Outstanding, K 43,980
  • Annual Sales, $ 120,980 K
  • Annual Income, $ -27,990 K
  • 36-Month Beta 0.61
  • Price/Sales 21.50
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.31
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/30/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.90 +2.17%
on 02/01/18
82.74 -1.34%
on 01/22/18
-0.17 (-0.21%)
since 01/09/18
3-Month
79.90 +2.17%
on 02/01/18
82.74 -1.34%
on 01/22/18
+0.63 (+0.78%)
since 11/09/17
52-Week
35.11 +132.50%
on 05/15/17
82.74 -1.34%
on 01/22/18
+46.38 (+131.57%)
since 02/09/17

Most Recent Stories

More News
Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer

Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ("AAA" or the "Company"), a Novartis company and a leader in nuclear medicine theragnostics, today announced that a subsidiary of Novartis AG (NYSE:NVS)...

AAAP : 81.63 (+0.16%)
NVS : 82.27 (+1.82%)
Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A.

Novartis International AG / Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A. . Processed and transmitted by Nasdaq Corporate Solutions. The...

AAAP : 81.63 (+0.16%)
NVS : 82.27 (+1.82%)
Pre-Market Technical Scan on Diagnostic Substances Equities -- Advanced Accelerator Applications, AMAG Pharma, DBV Technologies, and IDEXX Labs

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AAAP, AMAG, DBVT, and IDXX which can be accessed for free by signing up to www.wallstequities.com/registration....

AAAP : 81.63 (+0.16%)
DBVT : 17.29 (-0.23%)
IDXX : 248.14 (+2.19%)
AMAG : 21.85 (-1.35%)
Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer

Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ("AAA" or the "Company"), a leader in nuclear medicine theragnostics, today announced that a subsidiary of Novartis AG (NYSE:NVS) ("Novartis"), Novartis...

AAAP : 81.63 (+0.16%)
NVS : 82.27 (+1.82%)
Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period

Novartis International AG / Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period . Processed and transmitted by Nasdaq Corporate...

AAAP : 81.63 (+0.16%)
NVS : 82.27 (+1.82%)
Valeant Pharmaceuticals (VRX) in Focus: Stock Moves 5.5% Higher

Valeant Pharmaceuticals International (VRX) was a big mover last session, as the company saw its shares nearly 6% on the day amid huge volumes.

AAAP : 81.63 (+0.16%)
VRX : 23.40 (-3.43%)
Novartis Buys French Radiopharmaceutical Company

Novartis (NVS) plans to acquire France-based Advanced Accelerator Applications. The takeover will add RadioLigand Therapy, Lutathera, in its portfolio with potential to drive growth in the near term.

AAAP : 81.63 (+0.16%)
LGND : 231.88 (-0.28%)
NVS : 82.27 (+1.82%)
GSK : 41.87 (+2.90%)
Advanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher

Advanced Accelerator (AAAP) was a big mover last session, as the company saw its shares more than 10% on the day amid huge volumes.

AAAP : 81.63 (+0.16%)
NVS : 82.27 (+1.82%)
MEIP : 4.00 (-0.99%)
Merck and Cooper Tire stumble; CalAtlantic leaps

NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:

CTB : 25.65 (-0.58%)
LNC : 64.57 (-0.39%)
AAAP : 81.63 (+0.16%)
STRA : 120.01 (+0.08%)
DYN : 12.81 (-2.51%)
ICON : 0.65 (+1.56%)
Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio

Novartis International AG / Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio . Processed and transmitted by Nasdaq Corporate Solutions. The...

AAAP : 81.63 (+0.16%)
NVS : 82.27 (+1.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade AAAP with:

Business Summary

Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The company, develops, produces and commercializes molecular nuclear medicine diagnostic and therapeutic products. Its products in clinical development include Lutathera, Somakit and Annexin V-128. The company's commercial products...

See More

Key Turning Points

2nd Resistance Point 82.28
1st Resistance Point 81.95
Last Price 81.63
1st Support Level 81.40
2nd Support Level 81.18

See More

52-Week High 82.74
Last Price 81.63
Fibonacci 61.8% 64.55
Fibonacci 50% 58.92
Fibonacci 38.2% 53.30
52-Week Low 35.11

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar